Shree Ganesh Remedies Ltd. (SGRL) Share Price Rises 9.36% Today
- September 1, 2026
- Posted by: Harsh Piplani
- Category: News
Shree Ganesh Remedies Ltd. Share Price climbed by Rs 56.7 to Rs 662.2 on 01 September 2026, a gain of 9.36% over the previous close of Rs 605.5. The stock opened at Rs 618, touched Rs 700, and the day’s low was also Rs 618. The move places the Healthcare company from the Pharmaceuticals & Drugs industry in focus, though the supplied dataset does not identify a company-specific catalyst.
From a valuation and profitability lens, the company trades at a P/E of 50.36 and a P/B of 4.74. ROE stands at 11.53%, ROCE at 14.63%, EPS at Rs 12.02, book value at Rs 127.82, and dividend yield at 0. For investors following Shree Ganesh Remedies Ltd. Share Price, the key question is not just the one-day rise, but how that rise sits against industry benchmarks and larger listed pharma peers.
Shree Ganesh Remedies Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 662.2 |
| Previous Close | Rs 605.5 |
| Today's Move | Rs 56.7 (+9.36%) |
| Open | Rs 618 |
| High | Rs 700 |
| Low | Rs 618 |
| Turnover | Rs 0.6 crore |
| Market Capitalisation | Rs 699.65 crore |
| Market Cap Category | Micro Cap |
Shree Ganesh Remedies Ltd. (SGRL) rose to Rs 662.2 from the previous close of Rs 605.5, a move of Rs 56.7 or 9.36%. The stock opened at Rs 618, reached a high of Rs 700, recorded a low of Rs 618.
Shree Ganesh Remedies Ltd. Share Price moved from Rs 605.5 to Rs 662.2, a one-session increase of Rs 56.7 or 9.36%. The stock opened at Rs 618 and never traded below that level during the session, with Rs 618 also marking the day’s low. It later touched an intraday high of Rs 700 before trading at Rs 662.2.
This price structure shows that the stock stayed above the previous close through the day. Turnover was Rs 0.6 crore, which gives added context to the move but does not, by itself, explain it. The verified data confirms a strong price rise; it does not confirm a specific trigger.
Shree Ganesh Remedies Ltd. (SGRL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 699.65 crore |
| P/E Ratio | 50.36x |
| P/B Ratio | 4.74x |
| ROE | 11.53% |
| ROCE | 14.63% |
| EPS | Rs 12.02 |
| Book Value Per Share | Rs 127.82 |
| Dividend Yield | 0% |
Shree Ganesh Remedies Ltd. (SGRL) fundamental metrics show P/E 50.36x, P/B 4.74x, ROE 11.53%, ROCE 14.63%. These figures provide context only and are not a buy or sell signal.
Shree Ganesh Remedies Ltd. has a market capitalisation of Rs 699.65 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 50.36x, P/B at 4.74x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.53% and ROCE of 14.63%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 12.02, book value per share of Rs 127.82, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.92x, median ROE of 11.81%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 50.36x |
| Benchmark Median P/E | 30.92x |
| Benchmark Average P/E | 48.02x |
| Benchmark P/E Range | 3.87x to 667.16x |
| Company P/B Ratio | 4.74x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 11.53% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 14.63% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 699.65 crore |
| Benchmark Median Market Cap | Rs 683.05 crore |
Shree Ganesh Remedies Ltd. (SGRL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Shree Ganesh Remedies Ltd. (SGRL) has a P/E ratio of 50.36x, which is above the benchmark median of 30.92x, a difference of +62.87%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Shree Ganesh Remedies Ltd. (SGRL) has a ROE of 11.53%, which is below the benchmark median of 11.81%, a difference of -2.37%. Shree Ganesh Remedies Ltd. (SGRL) has a ROCE of 14.63%, which is above the benchmark median of 13.65%, a difference of +7.18%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,60,696.31 | 38.8 | 5.43 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,46,062.83 | 83.91 | 13.89 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,91,515.22 | 86.82 | 21.1 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,18,403.7 | 25.69 | 4.3 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,554.33 | 33.94 | 3.25 | 11.83 | 16 |
Shree Ganesh Remedies Ltd. (SGRL) has a P/E ratio of 50.36x compared with the displayed peer median of 38.8x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.53% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 14.63% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Shree Ganesh Remedies Ltd. (SGRL) has a market capitalisation of Rs 699.65 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Shree Ganesh Remedies Ltd.
- Sharp move: The stock rose Rs 56.7, or 9.36%, to Rs 662.2.
- Strong session range: It opened at Rs 618, hit Rs 700, and the low was Rs 618.
- Valuation in focus: P/E is 50.36 and P/B is 4.74.
- Return profile: ROE is 11.53% and ROCE is 14.63%.
- Industry context: P/E is above the same-industry median of 30.92, while ROCE is above the median of 13.65%.
About Shree Ganesh Remedies Ltd.
Shree Ganesh Remedies Ltd. is a listed company in the Healthcare sector and Pharmaceuticals & Drugs industry. Based on the supplied benchmark data, it operates in the same broader industry set as Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Cipla, Laurus Labs, Lupin, Mankind Pharma, Dr. Reddy’s Laboratories, and Aurobindo Pharma.
Track Shree Ganesh Remedies Ltd. Share Price on Univest
Use Shree Ganesh Remedies Ltd. (SGRL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Use the Shree Ganesh Remedies Ltd. (SGRL) live share-price page, the Univest top gainers screener, and Univest market blogs to follow live price data, market movers, and related market analysis in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Shree Ganesh Remedies Ltd. Share Price today?
Ans. Shree Ganesh Remedies Ltd. Share Price today is Rs 662.2, up Rs 56.7 or 9.36% from the previous close of Rs 605.5. The previous close was Rs 605.5. The stock moved 9.36% during the session.
How does valuation compare with the industry?
Ans. The company’s P/E of 50.36 is above the industry median of 30.92 and slightly above the industry average of 48.02. Its P/B of 4.74 is above the median of 2.88 and the average of 4.34.
